Evidence map›Paper›PMID 31383551›Full record

ArticleEBioMedicine2019

The imprinted gene Delta like non-canonical notch ligand 1 (Dlk1) associates with obesity and triggers insulin resistance through inhibition of skeletal muscle glucose uptake.

Charlotte Harken Jensen, Rok Kosmina, Mikael Rydén, Christina Baun, Svend Hvidsten, Marianne Skovsager Andersen, Louise Lehmann Christensen, Amalia Gastaldelli, Paolo Marraccini, Peter Arner and 4 more

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. CTNNB1 Genetic Variation and Its Interaction With DLK1 in Type 2 Diabetes Mellitus.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Shared Pathophysiological Mechanisms and Genetic Factors in Early Menarche and Polycystic Ovary Syndrome.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Charlotte Harken JensenLaboratory of Molecular and Cellular Cardiology, Dep. of Clinical Biochemistry and Pharmacology, Odense University Hospital, Denmark; Danish Center for Regenerative Medicine (danishcrm.com), Odense University Hospital, Denmark.
Rok KosminaLaboratory of Molecular and Cellular Cardiology, Dep. of Clinical Biochemistry and Pharmacology, Odense University Hospital, Denmark; The Danish Diabetes Academy, Denmark; Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Mikael RydénDep. of Medicine-H7, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Christina BaunDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Svend HvidstenDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Marianne Skovsager AndersenDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.
Louise Lehmann ChristensenDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.
Amalia GastaldelliInstitute of Clinical Physiology, CNR, Pisa, Italy.
Paolo MarracciniInstitute of Clinical Physiology, CNR, Pisa, Italy.
Peter ArnerDep. of Medicine-H7, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Christian Damsgaard JørgensenDepartment of Mathematics and Computer Science, University of Southern Denmark, Odense, Denmark.
Jorge LabordaDepartment of Inorganic and Organic Chemistry and Biochemistry, University of Castilla-La Mancha, Pharmacy School, Albacete, Spain.
Jens Juul HolstDepartment of Endocrinology and Metabolism, Section for Translational Metabolic Physiology, University of Copenhagen, Denmark.
Ditte Caroline AndersenLaboratory of Molecular and Cellular Cardiology, Dep. of Clinical Biochemistry and Pharmacology, Odense University Hospital, Denmark; Danish Center for Regenerative Medicine (danishcrm.com), Odense University Hospital, Denmark; Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Clinical Institute, University of Southern Denmark, Odense, Denmark. Electronic address: dandersen@health.sdu.dk.
Odense University Hospital · DKUniversity of Southern Denmark · DKIstituto di Fisiologia Clinica · ITKarolinska University Hospital · SEUniversity of Castilla-La Mancha · ESUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe imprinted gene Delta like non-canonical Notch ligand 1 (Dlk1) is considered an inhibitor of adipogenesis, but its in vivo impact on fat mass indeed remains elusive and controversial.

methodsFat deposits were assessed by MRI and DXA scanning in two cohorts of non-diabetic men, whereas glucose disposal rate (GDR) was determined during euglycemic hyperinsulinemic clamp. Blood analyte measurements were used for correlation and mediation analysis to investigate how age, BMI, and fat percentage affect the relation between DLK1 and GDR. Confirmatory animal studies performed in normal (NC) and high fat diet (HFD) fed Dlk1

findingsOverall, DLK1 is positively correlated with fat amounts, which is consistent with a negative linear relationship between DLK1 and GDR. This relationship is not mediated by age, BMI, or fat percentage. In support, DLK1 also correlates positively with HOMA-IR and ADIPO-IR in these humans, but has no linear relationship with the early diabetic inflammation marker MCP-1. In Dlk1

interpretationThus, instead of an adipogenic inhibitor, Dlk1 should be regarded as a factor causally linked to obesity and insulin resistance, and may be used to predict development of type 2 diabetes. FUND: The Danish Diabetes Academy supported by the Novo Nordisk Foundation, The Danish National Research Council (#09-073648), The Lundbeck Foundation, University of Southern Denmark, and Dep. Of Clinical Biochemistry and Pharmacology/Odense University Hospital, the Swedish Research Council, the Swedish Diabetes Foundation, the Strategic Research Program in Diabetes at Karolinska Institute and an EFSD/Lilly grant.

Indexed as

Genomic ImprintingInsulin ResistanceAdipose TissueAdiposityAdultAnimalsCalcium-Binding ProteinsCell LineDisease Models, AnimalFemaleGlucoseHumansMaleMiceMice, KnockoutMiddle AgedCalcium-Binding ProteinsDlk1 protein, mouseGlucoseDlk1Glucose uptakeInsulin resistanceObesityType 2 diabetes

Identifiers

PMID31383551
PMCPMC6711890
OpenAlexW2964663324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.